...
首页> 外文期刊>International journal of biological sciences >Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives
【24h】

Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives

机译:IgA肾病中的免疫促进酶:最先进的和未来的观点

获取原文

摘要

IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and renal failure. The exactpathogenesis of IgAN is not well defined, but some genetic studies have led to a novel discovery that theimmunoproteasome probably plays an important role in IgAN. The immunoproteasome is a proteasomevariant that is expressed when cells are stressed or receive inflammatory signals. Whileimmunoproteasome is suggested to be mainly involved in major histocompatibility complex-I (MHC-I)antigen presentation, recent studies indicate that it may assert broad functions in trafficking events thatactivate both innate and adaptive immunity. In this review, we first summarize new insights into itsfunctions in immunity, and discuss how it underlies its associations with IgAN. We also highlight itspotential as a therapeutic target for the future.
机译:IgA肾病(Igan)是慢性肾病和肾衰竭的主要原因。 IGAN的教育血症未定义不明确,但一些遗传研究导致了一种新的发现,即神经冲击液可能在IGAN中发挥重要作用。免疫促审米是当细胞应激或接受炎症信号时表达的蛋白酶体畸形。虽然ImmunoprooteAsome建议主要参与主要的组织相容性综合性综合体 - I(MHC-I)抗原呈现,最近的研究表明,它可能在贩运事件中致力于捕捉生物和适应症豁免的广泛功能。在这篇综述中,我们首先将新的见解总结到豁免中的职业障碍,并讨论其与IGAN的协会如何实现。我们还将itspotential突出为未来的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号